Morningstar [MORN] vs Moody's [MCO] Detailed Stock Comparison

Morningstar
NASDAQ
Loading...

Moody's
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Morningstar wins in 10 metrics, Moody's wins in 10 metrics, with 0 ties. Both stocks appear equally matched on key metrics.
View Metrics Details
Vital Metrics Comparison
Metric | Morningstar | Moody's | Better |
---|---|---|---|
P/E Ratio (TTM) | 27.60 | 43.24 | Morningstar |
Price-to-Book Ratio | 6.78 | 23.14 | Morningstar |
Debt-to-Equity Ratio | 64.05 | 179.87 | Morningstar |
PEG Ratio | 0.89 | 6.90 | Morningstar |
EV/EBITDA | 20.75 | 28.92 | Morningstar |
Profit Margin (TTM) | 17.22% | 29.18% | Moody's |
Operating Margin (TTM) | 20.54% | 44.68% | Moody's |
EBITDA Margin (TTM) | 20.54% | 44.68% | Moody's |
Return on Equity | 26.51% | 53.02% | Moody's |
Return on Assets (TTM) | 8.14% | 12.75% | Moody's |
Free Cash Flow (TTM) | $448.90M | $2.52B | Moody's |
Dividend Yield | 0.71% | 0.56% | Morningstar |
1-Year Return | -17.58% | 6.28% | Moody's |
Price-to-Sales Ratio (TTM) | 4.66 | 12.50 | Morningstar |
Enterprise Value | $11.47B | $97.89B | Moody's |
EV/Revenue Ratio | 4.89 | 13.40 | Morningstar |
Gross Profit Margin (TTM) | 61.89% | 74.24% | Moody's |
Revenue per Share (TTM) | $55 | $40 | Morningstar |
Earnings per Share (Diluted) | $9.40 | $11.78 | Moody's |
Beta (Stock Volatility) | 0.96 | 1.40 | Morningstar |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Morningstar vs Moody's Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
Morningstar | -1.38% | -0.16% | -8.53% | -15.42% | -19.81% | -22.18% |
Moody's | -1.06% | -2.27% | 1.86% | 7.76% | 1.84% | 7.75% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
Morningstar | -17.58% | 11.66% | 59.92% | 221.13% | 525.11% | 779.53% |
Moody's | 6.28% | 73.93% | 73.06% | 388.04% | 2,276.26% | 944.42% |
Performance & Financial Health Analysis: Morningstar vs Moody's
Metric | MORN | MCO |
---|---|---|
Market Information | ||
Market Cap | $10.94B | $91.36B |
Market Cap Category | Large cap | Large cap |
10 Day Avg. Volume | 228,353 | 515,649 |
90 Day Avg. Volume | 313,001 | 734,040 |
Last Close | $258.67 | $509.47 |
52 Week Range | $250.34 - $365.00 | $378.71 - $531.93 |
% from 52W High | -29.13% | -4.22% |
All-Time High | $365.00 (Dec 16, 2024) | $531.93 (Feb 10, 2025) |
% from All-Time High | -29.13% | -4.22% |
Growth Metrics | ||
Quarterly Revenue Growth | 0.06% | 0.05% |
Quarterly Earnings Growth | 0.29% | 0.05% |
Financial Health | ||
Profit Margin (TTM) | 0.17% | 0.29% |
Operating Margin (TTM) | 0.21% | 0.45% |
Return on Equity (TTM) | 0.27% | 0.53% |
Debt to Equity (MRQ) | 64.05 | 179.87 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | $38.28 | $22.02 |
Cash per Share (MRQ) | $12.84 | $12.77 |
Operating Cash Flow (TTM) | $535.30M | $2.68B |
Levered Free Cash Flow (TTM) | $438.26M | $2.08B |
Dividends | ||
Last 12-Month Dividend Yield | 0.71% | 0.56% |
Last 12-Month Dividend | $2.20 | $2.64 |
Valuation & Enterprise Metrics Analysis: Morningstar vs Moody's
Metric | MORN | MCO |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | 27.60 | 43.24 |
Forward P/E | 28.73 | 38.24 |
PEG Ratio | 0.89 | 6.90 |
Price to Sales (TTM) | 4.66 | 12.50 |
Price to Book (MRQ) | 6.78 | 23.14 |
Market Capitalization | ||
Market Capitalization | $10.94B | $91.36B |
Enterprise Value | $11.47B | $97.89B |
Enterprise Value Metrics | ||
Enterprise to Revenue | 4.89 | 13.40 |
Enterprise to EBITDA | 20.75 | 28.92 |
Risk & Other Metrics | ||
Beta | 0.96 | 1.40 |
Book Value per Share (MRQ) | $38.28 | $22.02 |
Financial Statements Comparison: Morningstar vs Moody's
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | MORN | MCO |
---|---|---|
Revenue/Sales | $581.90M | $1.92B |
Cost of Goods Sold | $231.40M | $491.00M |
Gross Profit | $350.50M | $1.43B |
Research & Development | N/A | N/A |
Operating Income (EBIT) | $114.10M | $881.00M |
EBITDA | $164.40M | $1.04B |
Pre-Tax Income | $108.50M | $804.00M |
Income Tax | $27.40M | $179.00M |
Net Income (Profit) | $78.50M | $625.00M |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | MORN | MCO |
---|---|---|
Cash & Equivalents | $511.50M | $2.14B |
Total Current Assets | $1.01B | $4.57B |
Total Current Liabilities | $912.30M | $2.92B |
Long-Term Debt | $965.40M | $7.03B |
Total Shareholders Equity | $1.61B | $3.86B |
Retained Earnings | $1.97B | $16.53B |
Property, Plant & Equipment | $1.22B | $2.40B |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | MORN | MCO |
---|---|---|
Operating Cash Flow | $85.70M | $1.04B |
Capital Expenditures | N/A | N/A |
Free Cash Flow | $58.80M | $672.00M |
Debt Repayment | $-40.00M | $-700.00M |
Common Stock Repurchase | $-109.60M | N/A |
Short Interest & Institutional Ownership Analysis
Metric | MORN | MCO |
---|---|---|
Shares Short | 513,657 | 1.64M |
Short Ratio | 1.59 | 2.02 |
Short % of Float | 0.02% | 0.01% |
Average Daily Volume (10 Day) | 228,353 | 515,649 |
Average Daily Volume (90 Day) | 313,001 | 734,040 |
Shares Outstanding | 42.87M | 180.31M |
Float Shares | 24.65M | 165.78M |
% Held by Insiders | 0.45% | 0.14% |
% Held by Institutions | 0.62% | 0.79% |
Dividend Analysis & Yield Comparison: Morningstar vs Moody's
Metric | MORN | MCO |
---|---|---|
Last 12-Month Dividend | $2.20 | $2.64 |
Last 12-Month Dividend Yield | 0.71% | 0.56% |
3-Year Avg Annual Dividend | $1.75 | $2.92 |
3-Year Avg Dividend Yield | 0.15% | 0.22% |
3-Year Total Dividends | $5.26 | $8.75 |
Ex-Dividend Date | Jul 11, 2025 | Feb 25, 2025 |